Allurion Technologies, Inc.

Allurion Technologies, LLC (formerly Allurion Technologies Opco, Inc., previously Allurion Technologies, Inc.) develops a weight loss platform called the Allurion Program. This platform aims to treat overweight individuals globally. The Allurion Program includes the Allurion Smart Capsule, which is a swallowable, Procedureless™ intragastric balloon for weight loss. It also provides access to the Allurion Virtual Care Suite (VCS), which consists of AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth. Over 200,000 patients have been commercially treated with the Allurion Smart Capsule in over 50 countries outside of the United States. The Allurion Program is designed to achieve metabolically healthy weight loss by promoting weight loss, maintaining that weight loss, and maintaining or increasing muscle mass. The Allurion Smart Capsule is swallowed as a capsule under healthcare provider guidance, without surgery, endoscopy, or anesthesia, with placement taking approximately 15 minutes during an outpatient visit.